Seattle Genetics (NASDAQ: SGEN) announced that the company and its collaborator, Takeda Pharmaceutical Company Limited (Takeda), completed patient enrollment in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE